Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Authors:
Top Cited Papers
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research Institute (ZIA BC 011801)
- Cancer Research Institute (CRI4239)
- National Cancer Institute (ZIA BC 011889)
- National Institutes of Health
- Research Grants Council, University Grants Committee
This publication has 108 references indexed in Scilit:
- Proteogenomic data and resources for pan-cancer analysisCancer Cell, 2023
- Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanomaCancer Cell, 2023
- Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapyCancer Cell, 2023
- Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesCancer Cell, 2022
- Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialCancer Cell, 2021
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyCancer Cell, 2019
- Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell TherapyCancer Cell, 2017
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaCell, 2016
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic ActivityCell, 2015
- Truncated product method for combiningP‐valuesGenetic Epidemiology, 2002